NASDAQ:SBTX
Delisted

Silverback Therapeutics Stock Signals

etoro logo Buy SBTX
*Your capital is at risk
$6.30
+0 (+0%)
At Close: Feb 07, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Silverback Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 69 days ( -2.61 %
Last Price $6.30 0 %
Performance History
7 Days
$6.30 $6.30
0%
30 Days
$7.23 $6.30
-12.86%
12 Mos
$4.19 $6.30
50.36%

9/18

Active Buy Signals

Specific Signals

Short Term
Net score: 40.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $6.30 - $6.30
Trend - 3 mos 14.03 % High Width: 29.27 %
Pred. range - 3 mos $6.92 - $8.95 Low 9.87 % - 42.04 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 27, 2023 - 8 days
RSI Short Pivot Signal Buy Very Low Feb 06, 2023 - 2 days
Short MA 3 mos Sell Low Jan 17, 2023 - 16 days
Long MA 3 mos Sell Medium Jan 26, 2023 - 9 days
Short/Long MA 3 mos Sell Medium Feb 01, 2023 - 5 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 59.84
Signal Type Signal Value Importance Data
Trend - 12 mos 76.54 % Very High Width: 44.96 %
Pred. range - 12 mos $9.62 - $13.94 High 52.64 % - 121.27 %
Short MA 12 mos Sell Very High Jan 18, 2023 - 15 days
Long MA 12 mos Buy Very High Jun 06, 2022 - 170 days
Short/Long MA 12 mos Buy Very High Jun 10, 2022 - 166 days
Pivot Long Buy Low Jan 27, 2023 - 8 days
RSI Long Pivot Signal Sell Low Jan 25, 2023 - 10 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SILVERBACK THERAPEUTICS, INC.
Silverback Therapeutics
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE